Bispecific Antibody
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
ASCO 2024: Covering Skin Cancer, Bispecific Antibody Treatment, TIGIT-Targeted Drugs, Radiotherapy and More
2024-05-29
Regeneron Pays CytomX $2 Billion Biobucks to Develop Bispecific Cancer Therapies Together
2022-11-17
Gilead and MacroGenics Strike Potential $1.7 billion Collaboration Over Bispecific Antibodies
2022-10-17
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24